Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Retraction]
Authors Hinz M, Stein A, Cole T
Received 24 February 2021
Accepted for publication 24 February 2021
Published 3 March 2021 Volume 2021:13 Pages 43—44
Hinz M, Stein A, Cole T. Clin Pharmacol. 2014;6:189–194.
The Editor-in-chief and Publisher of Clinical Pharmacology: Advances and Applications wish to retract the published article.
This perspective article cites several original research articles published by the authors, which have recently been retracted. This article draws on the findings from those original research articles to form central arguments and discussion, and as a result of the research articles’ retraction, the argument presented in this article is no longer valid and the editor has determined it should be retracted.
Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]